Sense Biodetection

We’ve always believed that if you can test anywhere, you can change everything. Today we take an exciting leap forward with @Sherlock_Bio to accelerate the development of powerful molecular diagnostics to transform healthcare by redefining diagnostics. lnkd.in/gjsUgKAe

Happy New Year from Sense! Our resolution is to improve patient access, and to help providers improve outcomes with instrument-free molecular diagnostics. What’s yours? #HappyNewYear

Veros™ revolutionary performance is made possible by Sense’s innovations in electromechanical design and advanced chemistry. Have a look at the inner workings of the Veros device. #Diagnostics #PointofCare

Veros COVID-19 is the first and only instrument-free molecular diagnostic test that provides high quality results in about 15 minutes right at the point of care. CE marked and available in select European and South American countries. #Diagnostics #PointofCare #Covid19Test

Over 1000x more sensitive than antigen, Veros COVID-19 has maintained 100% conservation in all Variants of Interest and Concern identified to date by the WHO and the US CDC to date, including Delta and Omicron BA.4 and BA.5 Available in select EU and South American countries.

“The virus has not disappeared” said French Prime Minister, "the COVID epidemic is starting again." politico.eu/article/french-p… Instrument-free Veros COVID-19 provides fast, molecular results in about 15 minutes. CE marked and available in select EU and South American countries.

Ryan Roberts, Sense’s CCO, will be presenting at World POC and At Home Diagnostics Summit on 30 November 2022. Hear how innovation and consumerism are shaping diagnostics' future: hubs.ly/Q01sPVxD0 We look forward to seeing you there! #PointofCare #Diagnostics

Sense is pleased to announce our entry into the Benelux region, partnering with R-Biopharm Nederland B.V. to introduce Veros™ COVID-19 in Netherlands, Belgium, and Luxembourg. For more information: sense-bio.com/sense-and-r-bi… Available in select EU and South American countries.

Veros COVID-19, a single-use, instrument-free test that delivers accurate #molecular results in about 15 minutes, is now available in Chile. Contact Biotecom, your local distributor for inquires: biotecom.cl/contacto/ #PointOfCare #COVIDTesting #Diagnostics

Sense’s CEO, Timothy I. Still, will be presenting at the Innovation Summit San Francisco 2022, #MedTech conference. Learn more about Veros™ – molecular quality results without an instrument in about 15 minutes. More info at: medtechstrategist.com/sf22/a… #POCT #Diagnostics

Sense is pleased to announce our partnership with Bio Nuclear Diagnostics to introduce Veros™ COVID-19 in Canada. For more information: lnkd.in/dHVtnKKC Available in select EU and South American countries. #PointofCare #Diagnostics #Partnership

Sense technologies deliver fast, accurate results, are instrument-free, and offer the flexibility to run one test or dozens at the same time. Learn more about how we are transforming healthcare by redefining diagnostics: sense-bio.com/about-sense/ #Sense #Diagnostics #PointofCare

Sense is pleased to announce our entry into South America, partnering with Biotecom to introduce Veros™ COVID-19 in Chile. For more information: sense-bio.com/sense-and-biot… #PointofCare #Diagnostics #Partnership

‘Escape variants’ BQ.1 and BQ.1.1 now account for 16% of COVID-19 cases. beckershospitalreview.com/pu… Veros COVID-19 delivers fast, accurate molecular results and is conserved across all known Variants of Concern to date. CE marked and available in select EU countries. #Diagnostics

Health experts warn of another COVID winter surge. With cases already rising in Europe, this could strain travel affected by labor shortages. lnkd.in/g2g_fTiF Veros COVID-19 provides fast and accurate results within minutes. Available in select EU countries.

Study in JAMA suggests the high diagnostic sensitivity of NAAT tests can rule out SARS-CoV-2 in ED patients with 1 negative test, avoiding unnecessary repeat testing. For more information: jamanetwork.com/journals/jam… #COVID19 #POCT #Diagnostics

Sense will be at IDweek and we are looking forward to seeing everyone there! Stop by booth #948 and say hello! #IDWeek2022 #PointofCareTesting #Diagnostics #InfectiousDisease

“Evidence is building that the Northern Hemisphere is on course for a surge of COVID-19 cases this autumn and winter.” For more: nature.com/articles/d41586-0… Give patients better convenience and accurate results in minutes with Veros COVID-19. Available in Select EU countries.

Sense and Abacus dx partner to introduce Veros™ COVID-19 to Australia and New Zealand. For more information: sense-bio.com/sense-and-abac… #PointofCare #Diagnostics #Partnership